Skip to content

Evaluation of the Physiopathological Phenomena and the Haemodynamic and Cerebral Metabolic Effects From Semi-seated Position to Lying Position in Patients With Brain Trauma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02832908
Acronym
PULSATILITY
Enrollment
90
Registered
2016-07-14
Start date
2014-12-31
Completion date
2016-12-31
Last updated
2016-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Brief summary

Brain trauma is an important burden in traumatologic intensive care. In these patients the treatment is guided by a cluster of multimodal monitoring parameters. Despite this it is difficult to assess the actual physiopathologic status of the brain. Changing the position of these patients (semi-seated to lying position) causes changes in the hémodynamics brain conditions, so in monitoring parameters . The analysis of these changes can givr us valuable clinically informations.

Detailed description

Severe brain trauma (CGS \< 8 ) are included. PIC, PA, PVC, EKG, airway pressure, SjO2 and NIRSS are continuously monitored. The patients are in semi seated (30°) position. Once a day they are in supine (0°) for 30 minutes. We record every parameters before and at the end of this supine period. After time domain and frequency domain signal processing, this parameters are compared to deduct clinical relevant conclusions.

Interventions

OTHERChange from semi-seated position to supine

from semi-seated position (30°) to lying position

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with a severe head trauma estimated by the Glasgow Coma Scale and by the Glasgow Outcome Scale * age \> 18

Exclusion criteria

* Other neurological pathology

Design outcomes

Primary

MeasureTime frame
ASSESSMENT OF THE CEREBRAL OXYGENATIONUP TO 6 MONTHS

Countries

France

Contacts

Primary ContactJean Paul ROUSTAN, MD
jp-roustan@chu-montpellier.fr0467338256

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026